Stock listing

NGM:PEXA.B PExA AB Aktie

Home listing (NGM) of PExA AB

Follow PExA AB into a list and get an email when it puts out news.

Ticker: NGM:PEXA.B
Asset type: Stock
Sector: Health care
Industry: Diagnostics & research services
Exchange: NGM
Currency: SEK

What changed lately

Latest news release · May 22, 2026
PEXA.B: Q1 2026 saw strong sales growth, improved results, and key research orders, but more funding is needed

Latest news

PEXA.B: Q1 2026 saw strong sales growth, improved results, and key research orders, but more funding is needed

May 22, 2026

PEXA.B: Strategic refocus on lung cancer diagnostics, narrowed losses, and improved cash position

Feb 19, 2026

PEXA.B: Q3 revenue up 41%, rights issue secures 9.9 MSEK for diagnostic expansion

Nov 7, 2025

PEXA.B: Revenue up, losses narrowed, and a guaranteed rights issue launched to fund clinical expansion

Aug 29, 2025

PEXA.B: No Q1 revenue as PEXA pivots to clinical focus; funding needed amid strong tech validation

May 9, 2025

PEXA.B: Net loss deepens as PEXA pivots to diagnostics, seeking capital amid scientific progress

Feb 20, 2025

PEXA.B: Sales and earnings fell, but strong equity and new funding support global expansion and R&D

Nov 8, 2024

PEXA.B: Revenue fell and losses increased, but new funding and scientific milestones support future growth

Aug 23, 2024

All PExA AB news

Decks

Investor Presentation (May 2024)
Investor deck · 19 slides · May 2024

PExA AB on 6ix

Sector: Health care
Industry: Diagnostics & research services
News releases: 3 in the last 12 months · 8 in all · newest May 22, 2026 · oldest 2024
Decks: 1 deck · latest May 2024

Where PExA AB is listed

Listing	Exchange	Country	Currency
NGM:PEXA.B · Home listing · This page	NGM	Sweden	SEK
Frankfurt:FA0	Frankfurt	Germany	EUR

Log in to ask 6ix AI your own questions about PExA AB.